These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6089236)

  • 1. Two types of calmodulin antagonists: a structurally related interaction.
    Inagaki M; Hidaka H
    Pharmacology; 1984; 29(2):75-84. PubMed ID: 6089236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calmodulin antagonists' binding sites on calmodulin.
    Tanaka T; Ohmura T; Hidaka H
    Pharmacology; 1983; 26(5):249-57. PubMed ID: 6304789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calmodulin antagonists enhance calcium binding to calmodulin.
    Inagaki M; Tanaka T; Hidaka H
    Pharmacology; 1983; 27(3):125-9. PubMed ID: 6622516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct interaction of calmodulin antagonists with Ca2+/calmodulin-dependent cyclic nucleotide phosphodiesterase.
    Itoh H; Hidaka H
    J Biochem; 1984 Dec; 96(6):1721-6. PubMed ID: 6099352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrophobic interaction of the Ca2+-calmodulin complex with calmodulin antagonists. Naphthalenesulfonamide derivatives.
    Tanaka T; Ohmura T; Hidaka H
    Mol Pharmacol; 1982 Sep; 22(2):403-7. PubMed ID: 7144734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of bovine rod outer segment phosphatidylinositol-4,5-bisphosphate phospholipase C by calmodulin antagonists does not depend on calmodulin.
    Gehm BD; Pinke RM; Laquerre S; Chafouleas JG; Schultz DA; Pepperl DJ; McConnell DG
    Biochemistry; 1991 Nov; 30(47):11302-6. PubMed ID: 1659898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrophobic properties of Tetrahymena calmodulin related to the phosphodiesterase activity.
    Inagaki M; Naka M; Nozawa Y; Hidaka H
    FEBS Lett; 1983 Jan; 151(1):67-70. PubMed ID: 6297991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symmetric covalent linkage of N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7) results in novel derivatives with increased inhibitory activities against calcium/calmodulin complex.
    Yokokura H; Osawa M; Inoue T; Umezawa I; Naito Y; Ikura M; Hidaka H
    Drug Des Discov; 1999 Nov; 16(3):203-16. PubMed ID: 10624566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium-induced exposure of a hydrophobic surface on calmodulin.
    LaPorte DC; Wierman BM; Storm DR
    Biochemistry; 1980 Aug; 19(16):3814-9. PubMed ID: 6250577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Slow calcium channel blockers and calmodulin. Effect of felodipine, nifedipine, prenylamine and bepridil on cardiac sarcolemmal calcium pumping ATPase.
    Lamers JM; Cysouw KJ; Verdouw PD
    Biochem Pharmacol; 1985 Nov; 34(21):3837-43. PubMed ID: 2933041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ca2+-dependent cyclic nucleotide phosphodiesterase is activated by poly(L-aspartic acid).
    Tanaka T; Ito M; Ohmura T; Hidaka H
    Biochemistry; 1985 Sep; 24(19):5281-4. PubMed ID: 3000429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A fluorescence polarization-based assay for the identification and evaluation of calmodulin antagonists.
    Arai T; Yatabe M; Furui M; Akatsuka H; Uehata M; Kamiyama T
    Anal Biochem; 2010 Oct; 405(2):147-52. PubMed ID: 20599654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlordecone interaction of calmodulin binding with phosphodiesterase.
    Vig PJ; Desaiah D; Mehrotra BD
    J Appl Toxicol; 1990 Feb; 10(1):55-7. PubMed ID: 1692334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Mg2+-binding sites and the role of Mg2+ on target recognition by calmodulin.
    Ohki S; Ikura M; Zhang M
    Biochemistry; 1997 Apr; 36(14):4309-16. PubMed ID: 9100027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for calmodulin inter-domain compaction in solution induced by W-7 binding.
    Osawa M; Kuwamoto S; Izumi Y; Yap KL; Ikura M; Shibanuma T; Yokokura H; Hidaka H; Matsushima N
    FEBS Lett; 1999 Jan; 442(2-3):173-7. PubMed ID: 9928996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of amiodarone and its analogs with calmodulin.
    Deziel MR; Davis PJ; Davis FB; Cody V; Galindo J; Blas SD
    Arch Biochem Biophys; 1989 Nov; 274(2):463-70. PubMed ID: 2552925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of the dihydropyridine calcium antagonist, CD-349, with calmodulin.
    Tanaka M; Muramatsu M; Aihara H; Otomo S
    Biochem Pharmacol; 1990 Sep; 40(5):991-6. PubMed ID: 2167684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro effects of organophosphorus compounds on calmodulin activity.
    Pala I; Vig PJ; Desaiah D; Srinivasan A
    J Appl Toxicol; 1991 Dec; 11(6):391-5. PubMed ID: 1761796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solution structure of calmodulin-W-7 complex: the basis of diversity in molecular recognition.
    Osawa M; Swindells MB; Tanikawa J; Tanaka T; Mase T; Furuya T; Ikura M
    J Mol Biol; 1998 Feb; 276(1):165-76. PubMed ID: 9514729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 1H-NMR comparison of calmodulin activation by calcium and by cadmium.
    Akiyama K; Sutoo D; Reid DG
    Jpn J Pharmacol; 1990 Jul; 53(3):393-401. PubMed ID: 2391767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.